ASX - By Stock
|
PEN |
Re:
Ann: Trading Halt
|
|
Stonks100
|
30 |
10K |
8 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
30
|
10K
|
8
|
|
ASX - By Stock
|
PNR |
Re:
Ann: Successful A$100M Equity Raising
|
|
Stonks100
|
45 |
14K |
6 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
45
|
14K
|
6
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Stonks100
|
4 |
1.2K |
0 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
4
|
1.2K
|
0
|
|
ASX - By Stock
|
FDR |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Stonks100
|
7 |
1.6K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7
|
1.6K
|
7
|
|
ASX - By Stock
|
MHC |
Re:
Ann: March 2024 Quarter Activities and Cashflow Reports
|
|
Stonks100
|
17 |
3.8K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
17
|
3.8K
|
3
|
|
ASX - By Stock
|
IXR |
Re:
Ann: IonicRE Raises $5.5 Million in a Placement
|
|
Stonks100
|
111 |
34K |
21 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
111
|
34K
|
21
|
|
ASX - By Stock
|
MHC |
Re:
Ann: New High Grade Gold Discovery
|
|
Stonks100
|
156 |
36K |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
156
|
36K
|
3
|
|
ASX - By Stock
|
AVA |
Re:
Ann: Trading Halt
|
|
Stonks100
|
39 |
11K |
11 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
39
|
11K
|
11
|
|
ASX - By Stock
|
MHC |
Re:
Ann: Ponton Uranium Project
|
|
Stonks100
|
299 |
88K |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
299
|
88K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Stonks100
|
272 |
101K |
9 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
272
|
101K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Stonks100
|
272 |
101K |
6 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
272
|
101K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Stonks100
|
272 |
101K |
21 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
272
|
101K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Stonks100
|
272 |
101K |
7 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
272
|
101K
|
7
|
|
ASX - By Stock
|
PEN |
Re:
Ann: A$10m SPP Closes Substantially Oversubscribed
|
|
Stonks100
|
172 |
64K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
172
|
64K
|
0
|
|
ASX - By Stock
|
PEN |
Re:
Ann: A$10m SPP Closes Substantially Oversubscribed
|
|
Stonks100
|
172 |
64K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
172
|
64K
|
0
|
|
ASX - By Stock
|
PEN |
Re:
Ann: A$10m SPP Closes Substantially Oversubscribed
|
|
Stonks100
|
172 |
64K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
172
|
64K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Stonks100
|
380 |
128K |
5 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
380
|
128K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Stonks100
|
380 |
128K |
7 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
128K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Stonks100
|
362 |
118K |
5 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
362
|
118K
|
5
|
|
ASX - By Stock
|
PPK |
Re:
PPK Value
|
|
Stonks100
|
273 |
77K |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
273
|
77K
|
0
|
|
ASX - By Stock
|
PPK |
Re:
PPK Value
|
|
Stonks100
|
273 |
77K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
273
|
77K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 Awarded $528k Contract with BAE Systems Maritime Aus
|
|
Stonks100
|
382 |
80K |
3 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
382
|
80K
|
3
|
|
ASX - By Stock
|
MHC |
Re:
Ann: Change in Substantial Holding
|
|
Stonks100
|
24 |
5.9K |
0 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
24
|
5.9K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
Ann: EOS update re dispute with lender WHSP
|
|
Stonks100
|
11 |
5.4K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
11
|
5.4K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
Ann: EOS update re dispute with lender WHSP
|
|
Stonks100
|
11 |
5.4K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
11
|
5.4K
|
0
|
|
Charts
|
MGT |
Re:
MGT share price
|
|
Stonks100
|
13K |
5.1M |
3 |
20/10/23 |
20/10/23 |
Charts
|
13K
|
5.1M
|
3
|
|
ASX - By Stock
|
ITM |
Re:
ITM Chart
|
|
Stonks100
|
646 |
197K |
1 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
646
|
197K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Notification of cessation of securities - ZIP
|
|
Stonks100
|
11 |
2.8K |
2 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
11
|
2.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Stonks100
|
574 |
193K |
8 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
193K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
What are your thoughts on funding?
|
|
Stonks100
|
52 |
15K |
11 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
52
|
15K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
The FDA is a corrupt organization.
|
|
Stonks100
|
155 |
56K |
15 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
155
|
56K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Time to buy MSB and ride the wave ?
|
|
Stonks100
|
144 |
54K |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
144
|
54K
|
3
|
|
ASX - By Stock
|
VML |
Re:
Ann: Trading Halt
|
|
Stonks100
|
53 |
26K |
2 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
53
|
26K
|
2
|
|
ASX - By Stock
|
VML |
Re:
Ann: Trading Halt
|
|
Stonks100
|
53 |
26K |
1 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
53
|
26K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Stonks100
|
3.4K |
1.1M |
3 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
EOS |
Re:
Ann: EOS Secures Contract (approximately A$51m) to Supply RWS
|
|
Stonks100
|
13 |
9.9K |
5 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
13
|
9.9K
|
5
|
|
ASX - By Stock
|
EOS |
Re:
Stock information?
|
|
Stonks100
|
60 |
43K |
1 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
60
|
43K
|
1
|
|
ASX - By Stock
|
AV1 |
Re:
Ann: Share Purchase Plan Offer Document
|
|
Stonks100
|
12 |
4.7K |
1 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
AV1 |
Re:
Ann: Share Purchase Plan Offer Document
|
|
Stonks100
|
12 |
4.7K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
12
|
4.7K
|
3
|
|
ASX - By Stock
|
EOS |
Re:
Ann: Q1 Cash Outcome and New Business Opportunities
|
|
Stonks100
|
45 |
27K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
45
|
27K
|
3
|
|
ASX - By Stock
|
EOS |
Re:
Ann: Q1 Cash Outcome and New Business Opportunities
|
|
Stonks100
|
45 |
27K |
0 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
45
|
27K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
Ann: Q1 Cash Outcome and New Business Opportunities
|
|
Stonks100
|
45 |
27K |
0 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
45
|
27K
|
0
|
|
ASX - By Stock
|
MHC |
Re:
Ann: Change of Registered Office and Business Address
|
|
Stonks100
|
6 |
2.5K |
2 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
6
|
2.5K
|
2
|
|
ASX - By Stock
|
PNR |
Re:
Ann: Production stoping commences at OK mine
|
|
Stonks100
|
10 |
6.9K |
4 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
10
|
6.9K
|
4
|
|
ASX - By Stock
|
MHC |
Re:
Ann: December 2022 Interim Financial Report
|
|
Stonks100
|
17 |
5.6K |
2 |
26/03/23 |
26/03/23 |
ASX - By Stock
|
17
|
5.6K
|
2
|
|
ASX - By Stock
|
PNR |
Re:
Ann: Euroz Hartleys Rottnest Conference Presentation
|
|
Stonks100
|
8 |
7.4K |
5 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
8
|
7.4K
|
5
|
|
ASX - By Stock
|
EOS |
Re:
Ann: FY2022 Reporting Date and Investor Call
|
|
Stonks100
|
13 |
5.5K |
11 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
13
|
5.5K
|
11
|
|
ASX - By Stock
|
EOS |
Re:
Ann: FY2022 Reporting Date and Investor Call
|
|
Stonks100
|
13 |
5.5K |
1 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
13
|
5.5K
|
1
|
|
ASX - By Stock
|
MHC |
Re:
Ann: District Scale Canadian Lithium Project
|
|
Stonks100
|
121 |
31K |
1 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
121
|
31K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
|
|
Stonks100
|
217 |
70K |
17 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
217
|
70K
|
17
|
|